Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Weighing the hazards of erythropoiesis stimulation in patients with cancer.

Khuri FR.

N Engl J Med. 2007 Jun 14;356(24):2445-8. No abstract available.

2.

What is the risk of bowel perforation associated with bevacizumab therapy in ovarian cancer?

Han ES, Monk BJ.

Gynecol Oncol. 2007 Apr;105(1):3-6. No abstract available.

PMID:
17383545
3.

Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia.

Wright JR, Ung YC, Julian JA, Pritchard KI, Whelan TJ, Smith C, Szechtman B, Roa W, Mulroy L, Rudinskas L, Gagnon B, Okawara GS, Levine MN.

J Clin Oncol. 2007 Mar 20;25(9):1027-32. Epub 2007 Feb 20.

PMID:
17312332
5.

Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study.

Leyland-Jones B, Semiglazov V, Pawlicki M, Pienkowski T, Tjulandin S, Manikhas G, Makhson A, Roth A, Dodwell D, Baselga J, Biakhov M, Valuckas K, Voznyi E, Liu X, Vercammen E.

J Clin Oncol. 2005 Sep 1;23(25):5960-72. Epub 2005 Aug 8.

PMID:
16087945
6.

Thromboembolic events in patients treated with definitive chemotherapy and radiation therapy for invasive cervical cancer.

Jacobson GM, Kamath RS, Smith BJ, Goodheart MJ.

Gynecol Oncol. 2005 Feb;96(2):470-4.

PMID:
15661237
8.

Association of hemoglobin level with survival in cervical carcinoma patients treated with concurrent cisplatin and radiotherapy: a Gynecologic Oncology Group Study.

Winter WE 3rd, Maxwell GL, Tian C, Sobel E, Rose GS, Thomas G, Carlson JW.

Gynecol Oncol. 2004 Aug;94(2):495-501.

PMID:
15297194
9.

The logrank test.

Bland JM, Altman DG.

BMJ. 2004 May 1;328(7447):1073. Review. No abstract available.

10.

Hypoxia and hypoxia inducible factors (HIF) as important regulators of tumor physiology.

Acker T, Plate KH.

Cancer Treat Res. 2004;117:219-48. Review.

PMID:
15015563
11.

Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial.

Henke M, Laszig R, Rübe C, Schäfer U, Haase KD, Schilcher B, Mose S, Beer KT, Burger U, Dougherty C, Frommhold H.

Lancet. 2003 Oct 18;362(9392):1255-60.

PMID:
14575968
12.
13.

Anemia in cervical cancers: impact on survival, patterns of relapse, and association with hypoxia and angiogenesis.

Dunst J, Kuhnt T, Strauss HG, Krause U, Pelz T, Koelbl H, Haensgen G.

Int J Radiat Oncol Biol Phys. 2003 Jul 1;56(3):778-87.

PMID:
12788185
14.

Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix.

Pearcey R, Brundage M, Drouin P, Jeffrey J, Johnston D, Lukka H, MacLean G, Souhami L, Stuart G, Tu D.

J Clin Oncol. 2002 Feb 15;20(4):966-72.

PMID:
11844818
15.

Tumor hypoxia, p53, and prognosis in cervical cancers.

Haensgen G, Krause U, Becker A, Stadler P, Lautenschlaeger C, Wohlrab W, Rath FW, Molls M, Dunst J.

Int J Radiat Oncol Biol Phys. 2001 Jul 15;50(4):865-72.

PMID:
11429213
16.

DNA-adduct levels as a predictor of outcome for NSCLC patients receiving daily cisplatin and radiotherapy.

van de Vaart PJ, Belderbos J, de Jong D, Sneeuw KC, Majoor D, Bartelink H, Begg AC.

Int J Cancer. 2000 Mar 20;89(2):160-6.

17.

Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome.

Brizel DM, Dodge RK, Clough RW, Dewhirst MW.

Radiother Oncol. 1999 Nov;53(2):113-7.

PMID:
10665787
18.

The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix.

Grogan M, Thomas GM, Melamed I, Wong FL, Pearcey RG, Joseph PK, Portelance L, Crook J, Jones KD.

Cancer. 1999 Oct 15;86(8):1528-36.

PMID:
10526282
19.

Improved treatment for cervical cancer--concurrent chemotherapy and radiotherapy.

Thomas GM.

N Engl J Med. 1999 Apr 15;340(15):1198-200. No abstract available.

PMID:
10202172
20.

Low hemoglobin is associated with increased serum levels of vascular endothelial growth factor (VEGF) in cancer patients. Does anemia stimulate angiogenesis?

Dunst J, Pigorsch S, Hänsgen G, Hintner I, Lautenschläger C, Becker A.

Strahlenther Onkol. 1999 Mar;175(3):93-6.

PMID:
10093609

Supplemental Content

Support Center